Gilead Sciences Inc. CEO Daniel O'Day's compensation rose 4.8% last year to $23.7 million — roughly $97 for every buck made ...

NEW YORK (Reuters) -Gilead Sciences set aside $200 million for ... drugmaker's promotional speakers program for HIV drugs. The Foster City, California-based company disclosed the potential ...

Gilead Sciences, Inc., a biopharmaceutical company ... The company was incorporated in 1987 and is headquartered in Foster City, California.

Your FREE insider update on the biggest news stories and investing trends, delivered midday TheChart of the Day belongs to the drug company Gilead Sciences (GILD) . I found the stock by using Barchart ...

We’re proud to once again be ranked in the top five of Americas Most Just companies in biopharma. The honor reflects our ongoing commitment to operate responsibly and empower our employees to help ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 2.6% in the company’s quarterly ...

Since the publication of my first article on the Foster City, California-based company, "Gilead Sciences: Seriously Undervalued At Peak Pessimism," its stock price has risen more than 60% ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Medicines Agency (EMA) has validated for parallel accelerated review the company’s ...

Gilead Sciences, Inc. is a research-based biopharmaceutical company ... Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Gilead Sciences, Inc. (GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in the areas of unmet medical need. The Foster City, California-based company ...